Acasti Pharma reported CAD981K in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acasti Pharma ACST:US C$ 0.98M 6.63M
Addus Homecare ADUS:US $ 11.58M 0.02M
Agile Therapeutics AGRX:US $ -16.77M 0.86M
Amarin AMRN:US $ -13.15M 20.96M
Bioscrip BIOS:US $ 35.48M 3.66M
Genetic Technologies GENE:US $ -3602520 127.42K
Pain Therapeutics PTIE:US $ -9.56M 4.44M